CERVICAL CANCER

This early-stage trial tests a new vaccine called PVX7 in 32 women with advanced cervical cancer who have finished their main treatment (surgery, radiation, or chemo). The goal is to see if the vaccine is safe and can boost the body's immune response against HPV, the virus that c…

This early-stage study tests an experimental drug called NX-1607 in adults with advanced cancers that have not responded to standard treatments. The drug works by boosting the immune system to fight tumors. The main goals are to check safety and find the right dose, with a later …

This early-stage study tests a new drug called BL-M07D1 in about 280 adults with advanced solid tumors that have the HER2 protein. The goal is to see if the drug is safe and helps shrink tumors. Participants must have tried at least two prior treatments and have a life expectancy…

This study tests a new drug, MK-2870, against standard treatments for people with cervical cancer that has come back or spread. About 686 participants will receive either MK-2870 or a treatment chosen by their doctor. The goal is to see if MK-2870 helps people live longer and shr…

This study compares proton therapy to standard photon therapy for cervical cancer that has spread to lymph nodes. The goal is to see if proton therapy causes less severe lymphopenia (a drop in infection-fighting white blood cells) and leads to better survival and fewer side effec…

This early-phase study tests a new drug, MGC026, in 250 adults with advanced solid tumors that have not responded to other treatments. The goal is to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants receive the drug through an IV and are…

This study looks at how well the drug T-DXd works in adults with advanced HER2-positive cancers that have spread and no longer respond to other treatments. About 100 people will take part, and researchers will track whether tumors shrink and how long the benefit lasts. The goal i…

This study tests a new radiation technique for people with cervical cancer or pelvic cancer that has come back. It is for those who cannot get standard brachytherapy because of unusual anatomy or large tumors. The goal is to see if this method can control the cancer in the treate…

This study tests a drug called sacituzumab govitecan in 20 people whose cervical cancer has returned or persisted after at least one prior chemotherapy. The drug works like a guided missile, delivering chemotherapy directly to cancer cells. The main goal is to see how many patien…

This study tests a combination of two drugs, Sac-TMT and QL1706, in about 89 women with recurrent or metastatic cervical cancer that cannot be treated with surgery or radiation. The main goal is to see how many patients' tumors shrink or disappear. Researchers will also track how…

This study tests a new drug, BMS-986340, alone or with other cancer drugs, in people with advanced solid tumors like lung, breast, or colon cancer. The goal is to find safe doses and check for side effects. About 949 adults whose cancer has worsened after standard treatment will …

This study tests a new drug called HLX43 in about 190 women with recurrent or metastatic cervical or ovarian cancer that did not respond to or could not tolerate standard first-line therapy. The drug is an antibody-drug conjugate that targets PD-L1, aiming to shrink tumors or slo…

This early-phase study tests a new drug called STRO-004 in adults with advanced solid tumors that have not responded to standard treatments. The study has three parts: finding a safe dose of STRO-004 alone, testing that dose in more people, and combining STRO-004 with another can…

This study tests a new immunotherapy for people with advanced HPV-related cancers, such as cervical, throat, anal, and penile cancers. Participants receive specially engineered immune cells designed to recognize and attack cancer cells infected with HPV type 16. The goal is to se…

This study tests a drug called ivonescimab in 50 people with advanced endometrial or cervical cancer that has worsened after standard chemotherapy. The drug targets two proteins (PD-1 and VEGF) to help the immune system fight the cancer and cut off its blood supply. The main goal…

This early-phase study tests an experimental oral drug, RGT-490, in adults with advanced solid tumors (including breast, ovarian, and endometrial cancers) that have a specific genetic change called PIK3CA. The main goals are to check safety, find the right dose, and see if the dr…

This study tests a new drug called volrustomig, either alone or with chemotherapy, in people with advanced or spreading solid tumors (cervical, head and neck, esophageal, or mesothelioma). The goal is to see if the drug can shrink tumors and control the disease. About 257 adults …

This study tests a new drug called 177LuBetaBart, which is a radioactive antibody that seeks out and delivers radiation directly to cancer cells. It is for people with several types of advanced solid tumors that have not responded to standard treatments. The goal is to find a saf…

This early-phase study tests a new treatment called VET3-TGI, a virus designed to infect and destroy cancer cells. It is given alone or with the immunotherapy atezolizumab to about 60 adults with advanced solid tumors that have not responded to standard treatments. The main goals…

This study tests a drug called belzutifan in people whose clear cell gynecologic cancer (ovarian, endometrial, cervical, or other) has come back or not gone away. The drug works by blocking a protein that helps tumors grow in low-oxygen conditions. About 32 participants will rece…

This study tests whether a non-invasive physical plasma treatment can clear HPV infections from the cervix. About 50 adults with HPV will receive the treatment, and researchers will check if the virus is gone afterward. The goal is to find a new way to prevent cervical cancer cau…

This early-stage study tests a new drug called TI-0093 in 12 people with HPV-16 positive cancers (like head and neck or cervical cancer) that have returned or spread. The main goal is to check safety and find the best dose. Researchers will monitor side effects and how the body r…

This study is testing a new robotic surgery system called Medtronic Hugo™ for hysterectomy procedures. About 70 adult patients with conditions like uterine fibroids, endometriosis, or certain cancers will take part. The goal is to see if the robot is safe and can successfully com…

This study tests different strategies to help people in Botswana start cervical cancer treatment sooner after diagnosis. Researchers will enroll 610 women with newly diagnosed invasive cervical cancer. The goal is to see which approaches work best to begin treatment within 90 day…

This early-phase study tests a new drug called BL-B01D1 in people with advanced lung cancer and other solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. About 470 adults will take part.

This study tests a new treatment called KD01, a modified virus that targets and kills cancer cells, in people with gynecologic cancers like cervical and endometrial cancer. The trial has two phases: Phase I includes patients whose cancer has not responded to standard treatments, …

This early-phase study is testing an experimental drug called DR-0202 in people with advanced solid tumors (like breast, lung, or pancreatic cancer) that have stopped responding to standard treatments. The main goal is to check the drug's safety and find the right dose. About 96 …

This study tests whether combining two drugs, pembrolizumab and lenvatinib, can slow or shrink tumors in people with cervical cancer that has come back or spread. About 30 adults with recurrent or metastatic cervical cancer will receive the combination. The goal is to see how wel…

This study tests a drug called MGD019 to see if it can help control advanced cervical cancer that has spread or come back. The trial involves 40 adults who have not yet received treatment for their cancer. The main goal is to see if the drug improves how long patients live.

This study tests a new drug called CNSI-Fe(II), which is injected directly into tumors. It uses iron to trigger a type of cell death called ferroptosis, aiming to shrink or control advanced solid tumors like lung, pancreas, and colorectal cancer. About 54 adults whose cancers hav…

This study tests whether adding a vitamin A-like drug (ATRA) to a platelet-boosting medication (romiplostim N01) works better than the platelet drug alone for cancer survivors whose platelet counts stay low after chemotherapy. About 220 adults with gynecologic, breast, or lung ca…

This study tests a new drug called TER-2013 in people with advanced solid tumors (like breast, endometrial, ovarian, lung, head and neck, esophageal, or cervical cancer) that have specific changes in the AKT/PI3K/PTEN pathway. The goal is to see if the drug is safe and shrinks tu…

This early-stage study tests a new treatment called CD70-targeted CAR-T cells in people with advanced solid tumors, including kidney, lung, and ovarian cancers. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells that have a specific marke…

This study tests whether adding the drug serplulimab to standard chemoradiotherapy can help control locally advanced cervical cancer. It involves 216 women who have not yet been treated. The main goal is to see if the combination delays cancer growth or improves survival.

This study tests a shorter course of radiation therapy combined with chemotherapy for cervical cancer. Normally, treatment takes 7-8 weeks, but this approach aims to finish in less time while still being effective. The trial includes 34 adults with advanced cervical cancer and wi…

This study tests an experimental drug called patritumab deruxtecan in people with advanced solid tumors that have spread or cannot be removed. The drug targets a protein called HER3 found on some cancer cells. About 740 adults with various cancers like lung, breast, or melanoma w…

This early-phase study tests a new drug, enzelkitug, alone or with standard immunotherapy, in adults with advanced solid tumors (e.g., lung, melanoma, breast, colon). The main goals are to check safety, find the right dose, and see if it shrinks tumors. About 450 participants wil…

This study tests two drugs, VS-6766 and defactinib, in people with certain recurrent gynecological cancers (like ovarian or endometrial cancer) that have specific gene changes. The goal is to see if the combination can shrink tumors and how safe it is. About 55 participants will …

This study tests whether giving a single dose of specially engineered immune cells (E7 TCR-T cells) before standard treatment can shrink or eliminate tumors in people with advanced HPV-related cancers. About 15 participants will have their own T cells collected, modified to targe…

This study tests a new drug called KRC-01, injected directly into the tumor, combined with standard radiation therapy for people with locally advanced cervical cancer. The trial has two parts: first, a small group to check safety and find the best dose; second, a larger group to …

This early-phase trial tests a new drug, ASTX660, combined with the immunotherapy pembrolizumab in people with advanced solid tumours, including cervical and triple-negative breast cancer. The goal is to see if blocking certain proteins can make cancer cells die in a way that tri…

This study tests a new drug called GI-101, either alone or with pembrolizumab or lenvatinib, in people with advanced solid tumors (cancers that have spread). The goal is to see if it is safe and works against the cancer. About 317 adults with certain cancers like lung, kidney, or…

This study tests a combination of two drugs, pembrolizumab and lenvatinib, in people with advanced cervical cancer that has not responded to previous treatment. The goal is to see if this combination can shrink tumors or slow cancer growth. About 35 participants will receive the …

This study tests a new drug, PRGN-2009, combined with pembrolizumab in 24 adults whose recurrent or metastatic cervical cancer no longer responds to pembrolizumab alone. The goal is to see if the combination can shrink tumors or stop them from growing. Participants must have HPV-…

This phase 3 trial tests whether adding the targeted drug sacituzumab tirumotecan to standard immunotherapy (pembrolizumab) and a blood-vessel blocker (bevacizumab) helps people with metastatic cervical cancer live longer or keep their cancer from growing. About 1,000 participant…

This early-phase trial tests a new drug called MDX2001 in people with advanced solid tumors that have spread. The main goals are to check the drug's safety and see if it can shrink tumors. About 285 adults with various cancers like lung, breast, or colon cancer will take part.

This study tests whether a newer, more precise type of radiation (online adaptive radiotherapy) can reduce side effects and better control cervical cancer compared to standard image-guided radiotherapy. About 124 women with advanced cervical cancer will receive either the new or …

This study tests a new drug called LY4052031 in people with advanced or spreading solid tumors, including bladder, breast, lung, and other cancers. The goal is to see if the drug is safe and works against these cancers. About 420 participants will take part, and the study will la…

This study tests an experimental drug called YL202 in about 100 adults with advanced solid tumors, including lung, colorectal, and cervical cancers that have not responded to other treatments. The main goal is to see if YL202 can shrink tumors. Participants will receive the drug …

This study tests whether adding a targeted radiation boost to the main tumor can help shrink large cervical cancers before internal radiation therapy begins. About 17 adults with bulky squamous cell carcinoma of the cervix will receive the extra boost during their standard 5-6 we…

This study tests an experimental oral drug called NEO212 in people with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it helps control the disease. About 134 adults will take part across t…

This study tests an experimental drug called MT-4561 in people with advanced solid tumors (like lung, breast, or pancreatic cancer) who have run out of standard options. The goal is to find a safe dose and see if the drug can shrink tumors. About 27 adults will take part in this …

This study tests a new drug called KIVU-107 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to target and kill cancer cells while limiting harm to healthy cells. The main goals are to find the safest dose and check fo…

This study tests whether adding the immunotherapy drug camrelizumab to standard chemotherapy can help prevent cervical cancer from coming back after surgery. It is for patients whose cancer has spread to nearby lymph nodes. About 59 participants will receive the combination treat…

This study tests whether a shorter, higher-dose radiation schedule (hypofractionated) is as safe and effective as the standard longer schedule for women with locally advanced cervical cancer. About 278 women in Uganda will receive either the shorter or standard radiation, plus ch…

This study looks at whether surgically removing enlarged lymph nodes before standard chemoradiation can help people with stage IIICr cervical cancer live longer without the cancer growing. About 452 participants will be randomly assigned to either have lymph node removal followed…

This study tests a combination of two or three drugs (BL-B01D1, pembrolizumab, and possibly bevacizumab) in people whose cervical or endometrial cancer has come back or spread. The goal is to see if the treatment shrinks tumors or slows the disease. About 96 adults aged 18-75 wit…

This study tests two experimental drugs, BL-B01D1 and SI-B003, alone or together in 130 women with recurrent or metastatic cervical cancer that has not responded to standard treatments. The goal is to see if these drugs can shrink tumors or slow disease progression. Participants …

This early-phase study tests a new drug called NRM-823, alone or with an immunotherapy, in 150 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. The study includes several cancer types lik…

This study tests whether combining two drugs, ZG005 and gecacitinib (with or without bevacizumab), is safe and can shrink tumors in people with advanced cervical cancer. About 120 women aged 18–75 whose cancer has spread or returned will take part. The goal is to find the best do…

This study tests whether adding a drug called tarlatamab to standard radiation therapy is safe and effective for cancers that have a protein called DLL3, such as certain lung cancers, melanomas, and bladder cancers. About 30 adults with advanced or returning cancers will receive …

This study tests a new drug that delivers radiation directly to cancer cells with a specific marker (GRPR). It is for adults with advanced cancers like prostate, breast, lung, or colon cancer that have come back or spread. The main goal is to find a safe dose and check for side e…

This study tests whether using MRI to guide brachytherapy (internal radiation) can better target tumors and reduce radiation exposure to nearby organs like the bladder and rectum. About 54 adults with cervical, uterine, vaginal, vulvar, or bladder cancer will receive treatment in…

This study is testing a small, AI-powered camera called the Pocket colposcope to see if it can accurately detect pre-cancerous changes in the cervix. About 1,054 women in Kenya who have tested positive for HPV will use the device during a routine exam. The goal is to find a simpl…

This study is testing a new blood test that looks for tiny pieces of HPV DNA shed by cervical cancer or pre-cancer cells. The goal is to see if this simple blood draw can tell the difference between early pre-cancer and invasive cancer, and help monitor patients without repeated …

This study is testing a new type of PET scan that targets a protein called Trop2, found on many solid tumors. Researchers want to see if this scan can find and measure tumors more accurately than current methods. About 400 adults with various cancers (like lung, bladder, or prost…

This study compares self-collected Pap smears to traditional doctor-administered ones for cervical cancer screening. Researchers want to see if the self-test is just as accurate, which could make screening easier for women in rural areas. About 250 women aged 21-65 who need routi…

This study looks at whether giving women a simple at-home kit to test for HPV (the virus that can cause cervical cancer) makes it easier for those who are overdue for screening to get tested. About 100 women aged 25-65 who haven't had a Pap smear in 3 years will receive a self-co…

This study is testing a blood test that looks for DNA signals from 20 different cancers, including lung, breast, and colon cancer. Researchers will see if the test can find cancer early and tell which type it is. In people with lung cancer, the test will also check for any cancer…

This study aims to create a single test that can detect endometrial, ovarian, and cervical cancers by looking for specific DNA changes in vaginal fluid or blood. Researchers at Mayo Clinic will enroll about 3,110 women to refine the test and see how accurately it identifies cance…

This study is testing a new type of PET/CT scan that uses a special tracer called 18F-T2 to find cancers that have high levels of a protein called CAIX. About 200 adults with cancers like kidney, bladder, lung, or breast cancer will get this scan to see if it works better than th…

This study compares two new technologies for detecting cervical cancer in Mozambique: a quick HPV test and a special imaging system. About 678 women aged 25-49 who have had an abnormal screening result will participate. The goal is to see if these tools are as accurate as current…

This study is testing a new way to detect cervical cancer using light instead of a traditional biopsy. Researchers are looking for unique light patterns (optical signatures) that can identify early abnormal cells. The study will involve 350 women who are already scheduled for a c…

This study explores whether women from underserved communities can accurately collect their own samples to test for HPV, the virus that can cause cervical cancer. Researchers will compare results from two different self-collection kits to standard Pap smears. The goal is to make …

This study is testing a new, affordable way to screen for cervical cancer using artificial intelligence. It analyzes urine samples and cervical images to detect high-risk HPV and precancerous changes. The goal is to provide a one-stop screening and triage system that works in low…

This study is testing whether offering a self-sampling kit for HPV (the virus that can cause cervical cancer) can encourage more women who haven't been screened in years to get tested. Researchers will compare different ways of offering the kit to find the best approach. The goal…

This study checks how well the HPV vaccine prevents cervical HPV infection in women in Sikkim, India, about 7 years after the vaccine was first given. Researchers will compare infection rates in married women aged 18 to 22 now and again in 2025-26. The goal is to give quick feedb…

This study aims to prevent unnecessary deaths from cervical cancer in Senegal by helping women overcome barriers to screening. Researchers will adapt a patient navigation program for both urban and rural areas and test it with about 900 women aged 25-69. The goal is to increase f…

This study tests whether a simple reminder from a general practitioner can increase the number of women who get screened for cervical cancer. About 11,200 women aged 25 to 65 in France who are behind on their screening will take part. The goal is to see if a doctor's involvement …

This study looks at how to better provide cervical cancer screening and treatment to women living with HIV in Nigeria. About 2,400 women will take part. The goal is to find the best way to combine cancer care with existing HIV services to prevent cervical cancer and improve healt…

This study tests a program that combines cervical cancer screening, nutrition education, protein supplements, and emotional support for women in India who have both HIV and HPV. The goal is to see if this approach can reduce persistent HPV infections, a key risk factor for cervic…

This study tests a new care strategy called DADA LINK to help more women in Kenya get screened for cervical cancer and receive treatment if needed. About 1,980 women aged 25-49 will take part. Clinics will use a mobile health platform and care coordinators to support screening an…

This study is testing whether starting pelvic floor physical therapy soon after radiation treatment can reduce bowel and bladder control problems in women with cervical cancer. About 28 women will receive the therapy and be checked for incontinence three months later. The goal is…

This study looks at whether using the Headspace mindfulness app before surgery or chemoradiation can help patients with endometrial or cervical cancer use fewer opioids and feel better. About 120 participants will be randomly assigned to use the app or not. The goal is to see if …

This study tests whether Reiki, a gentle hands-on energy therapy, can reduce anxiety and pain in people receiving brachytherapy (internal radiation) for gynecologic cancers like endometrial, cervical, vaginal, or vulvar cancer. About 70 participants will be randomly assigned to r…

This early-phase study tests whether fecal microbiota transplantation (FMT) can safely reduce severe diarrhea or colon inflammation caused by immune-checkpoint inhibitors in people with genitourinary and other cancers. About 40 participants will receive FMT and be monitored for s…

This study compares a 1-week radiation schedule to a standard 6-8 week schedule for relieving pain in people with advanced cervical cancer that cannot be cured. The goal is to see if the shorter treatment provides faster and effective pain relief. About 230 participants will be e…

This study looks at possible eye-related side effects in people with cervical cancer that has returned or spread, who are being treated with the drug TIVDAK. About 100 participants will receive TIVDAK every three weeks and undergo regular eye exams before, during, and after treat…

This study tests a new way to deliver radiation for cervical cancer. Instead of using one fixed plan for weeks, an AI adjusts the radiation daily based on the tumor's position, and weekly MRI scans provide extra guidance. The goal is to reduce side effects like bladder and bowel …

This study tests a precise type of proton radiation given after surgery for cervical, uterine, or endometrial cancer. The goal is to see if it causes fewer bowel side effects than standard radiation. About 25 adults who need pelvic radiation after surgery will take part.

This study tests whether a newer type of scan, PET/MRI, is better than the standard PET/CT at finding cancer spread to lymph nodes in people with locally advanced cervical cancer. About 50 adults with stage IB2 to IVA cervical cancer will receive both scans before treatment. The …

This study is collecting tumor, blood, and plasma samples from over 1,000 people with certain cancers (ovarian, breast, head and neck, cervical, vulva, and sarcoma). The goal is to find new markers that link tumor genetics and immune response to how the disease behaves. Participa…

This study looks at how the amount and storage of a dye called indocyanine green (ICG) affect its ability to find sentinel lymph nodes in people with cervical, endometrial, or vulvar cancer. The goal is to find the most effective and cost-saving way to use ICG during surgery. Abo…

This study tests a faster way to screen and treat cervical cancer in women living with HIV in the Dominican Republic. Researchers will compare same-day HPV testing and treatment to the usual approach. The goal is to see if more women complete the full screening process, which cou…

This study tests whether peer-to-peer education and support can help more adolescents and young adults living with HIV in Zambia get screened for cancer and complete their cancer treatment. Researchers will enroll 4,100 people aged 15-39 who are on HIV medication. The goal is to …

This study looks at when to send messages to encourage physical activity in older adults (65+) who have survived certain cancers and live with chronic pain. Researchers will track activity levels and pain ratings to find the best timing for these prompts. The goal is to learn how…

This study is testing whether HPV DNA found in blood and urine can be used to detect cervical cancer and monitor how well treatment is working. Researchers will collect samples from 30 women newly diagnosed with cervical cancer, before and after their treatment. The goal is to se…

This study looks at whether a special PET scan and a blood test for HPV can find leftover cancer cells in people with cervical cancer after they finish standard chemoradiation. About 64 adults with stage IB-IVA cervical cancer will take part. The goal is to see how well these tes…

This study looks at whether offering cervical cancer screening together with family planning services helps more women get screened. About 14,600 women aged 30-49 or those living with HIV in two regions of Mozambique will take part. The goal is to see if combining these services …

This study aims to understand how the tumor's surroundings change during chemoradiotherapy for locally advanced cervical and pancreatic cancers. Researchers will collect tissue and blood samples before, during, and after treatment from about 60 participants. The goal is to learn …

This study looks at whether changes in a blood marker called CRP can help predict how well immunotherapy works in women with advanced gynecological cancers (cervical, endometrial, ovarian, or vulvar). Researchers will follow 120 women receiving immunotherapy plus chemotherapy and…

This study is testing a mobile health tool called mSaada to help community health workers screen women for cervical cancer in western Kenya. Researchers will work with 6,000 women and health volunteers to see if the app makes screening easier and more effective. The goal is to fi…

This study looks at whether a simple blood test can find HPV DNA in people with HPV-related anal or cervical cancer who are getting radiation therapy. Researchers will take blood samples before, during, and after treatment to see if the virus's genetic material shows up and if it…

This study is testing a new device called the Calla introducer to see if women prefer it over the standard speculum during cervical cancer screening. Researchers will interview and survey about 305 healthy women aged 21-65 to gather their opinions. The goal is to improve the scre…

This study is testing whether liquid biopsies (blood tests that look for bits of HPV DNA) can help doctors monitor how well treatment is working for HPV-related cancers, like cervical and oropharyngeal cancer. Researchers will follow 480 people for up to 4 years, collecting sampl…

This study is collecting blood and tumor samples from 1100 people with various cancers (like head and neck, ovarian, and lung cancer) to learn how immune cells called T cells behave. The goal is to understand why some cancers are better at hiding from the immune system. Participa…

This study explores whether a simple self-sampling kit for HPV can help screen for cervical cancer in women aged 30-60 in Zaporizhzhia, Ukraine, during the ongoing war. Participants collect their own sample at home or a clinic and send it for testing. The goal is to see if this a…

This study tests a program called CARES that provides advocacy, resources, education, and support to rural cancer patients. The goal is to see if it helps them start treatment sooner after diagnosis and finish it faster. The study will include 320 adults with solid tumors like lu…

This study is testing two new blood tests that look for HPV DNA and RNA to see how well cervical cancer responds to standard treatments like surgery, radiation, and chemotherapy. About 55 adults with HPV-related cervical cancer will give blood samples before and after treatment. …

This early-phase study is testing a new substance called RAD301 in 9 healthy volunteers and people with certain cancers (pancreatic, lung, esophageal, cervical, endometrial, or ovarian). The goal is to see how the body absorbs and handles the radiation from RAD301, and whether it…

This study tests whether artificial intelligence can help more women in the Occitanie region of France complete cervical cancer screening. Researchers will invite 3,000 women aged 30-65 who haven't had a Pap smear in 4 years to use an HPV self-sampling kit. The goal is to see if …

This study looks at whether people with certain cancers prefer getting their immunotherapy (nivolumab or pembrolizumab) as a shot under the skin or as an IV drip. About 880 patients will try both methods and say which they like better. The goal is to understand patient preference…